This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
amino acid | 1057 |
amino acids | 1022 |
sialic acid | 788 |
sialic acids | 397 |
fatty acids | 380 |
mass spectrometry | 375 |
cancer cells | 292 |
neu gc | 239 |
cell lines | 229 |
fatty acid | 218 |
pomegranate juice | 218 |
glutamic acid | 197 |
acid residues | 180 |
neu ac | 176 |
escherichia coli | 176 |
biological activity | 175 |
antimicrobial peptides | 173 |
gallic acid | 172 |
solid phase | 166 |
lactic acid | 161 |
influenza virus | 156 |
tannic acid | 150 |
acetic acid | 150 |
nucleic acid | 149 |
breast cancer | 146 |
punica granatum | 144 |
cell surface | 143 |
antimicrobial activity | 140 |
plasma membrane | 139 |
gene expression | 138 |
present study | 135 |
ellagic acid | 133 |
binding sites | 132 |
signi fi | 132 |
peptide synthesis | 131 |
side chain | 128 |
molecular weight | 120 |
important role | 118 |
cancer cell | 113 |
prostate cancer | 110 |
fish oil | 109 |
hairy roots | 109 |
nucleic acids | 109 |
immune response | 109 |
binding site | 106 |
antibacterial activity | 104 |
nitric oxide | 104 |
inhibitory activity | 103 |
affi nity | 101 |
cell line | 101 |
cell proliferation | 100 |
nervous system | 99 |
mg kg | 97 |
secondary structure | 96 |
immune system | 96 |
cell membrane | 96 |
antioxidant activity | 96 |
laser desorption | 94 |
side chains | 94 |
chlorogenic acid | 94 |
active site | 91 |
cell death | 89 |
oxidative stress | 87 |
ms ms | 86 |
results suggest | 85 |
antiviral activity | 85 |
tumor cells | 84 |
desorption ionization | 83 |
citric acid | 83 |
caffeic acid | 82 |
epithelial cells | 82 |
growth factor | 82 |
wide range | 81 |
staphylococcus aureus | 80 |
pomegranate fruit | 79 |
drug delivery | 79 |
phase peptide | 79 |
building blocks | 79 |
acid sequence | 79 |
endothelial cells | 77 |
secondary metabolites | 76 |
modifi ed | 76 |
blood pressure | 76 |
negative bacteria | 75 |
liquid chromatography | 74 |
virus infection | 73 |
fi rst | 73 |
click chemistry | 72 |
phenolic compounds | 72 |
hairy root | 72 |
fi cantly | 71 |
wild type | 71 |
clinical trials | 71 |
two different | 71 |
cellular uptake | 71 |
tof ms | 70 |
antimicrobial peptide | 70 |
acid binding | 69 |
phenolic acids | 69 |
inhibitory effect | 69 |
biologically active | 69 |
cell wall | 69 |
central nervous | 68 |
mass spectrometric | 67 |
cord uid | 67 |
organic acids | 67 |
high affinity | 67 |
chemical synthesis | 67 |
doc id | 67 |
body weight | 66 |
results showed | 66 |
cell adhesion | 66 |
pr virus | 66 |
protein synthesis | 66 |
phase synthesis | 65 |
skeletal muscle | 64 |
tca cycle | 64 |
cell growth | 64 |
seed oil | 64 |
mg ml | 64 |
mammalian cells | 63 |
acid production | 63 |
assisted laser | 63 |
large number | 63 |
type i | 62 |
widely used | 62 |
identifi ed | 62 |
results indicate | 61 |
saccharomyces cerevisiae | 60 |
acid derivatives | 60 |
natural products | 60 |
dependent manner | 60 |
protein kinase | 60 |
carboxylic acid | 60 |
fl uorescence | 60 |
acetylated sialic | 60 |
dicaffeoylquinic acid | 59 |
negatively charged | 59 |
molecular dynamics | 59 |
arachidonic acid | 59 |
small molecules | 59 |
leucine aminopeptidase | 58 |
metal ions | 58 |
polyalthic acid | 58 |
effi cient | 58 |
naturally occurring | 57 |
glutamic acids | 57 |
acid residue | 57 |
signifi cant | 57 |
fi cant | 57 |
cell types | 56 |
pomegranate extract | 56 |
nmr spectroscopy | 56 |
spinal cord | 56 |
immune responses | 56 |
may also | 56 |
host cell | 56 |
signal transduction | 56 |
biological activities | 55 |
animal models | 55 |
red wine | 55 |
necrosis factor | 55 |
linked sialic | 55 |
side effects | 54 |
cancer therapy | 54 |
acid composition | 54 |
synthetic peptides | 54 |
cyclic peptides | 54 |
penetrating peptides | 54 |
rheumatoid arthritis | 53 |
molecular mass | 53 |
results show | 53 |
galla chinensis | 53 |
binding domain | 53 |
purifi cation | 52 |
fruit extract | 52 |
polyunsaturated fatty | 52 |
gel electrophoresis | 52 |
carbon source | 52 |
lung cancer | 52 |
different types | 51 |
modifi cation | 51 |
drug discovery | 51 |
human serum | 51 |
tumor necrosis | 51 |
present work | 51 |
binding protein | 51 |
acetylneuraminic acid | 50 |
cell membranes | 50 |
binding proteins | 50 |
root cultures | 50 |
pomegranate seed | 50 |
recent years | 50 |
gum arabic | 50 |
structural characterization | 50 |
purifi ed | 50 |
acid metabolism | 49 |
activity relationship | 48 |
aspartic acid | 48 |
systematic review | 48 |
infected mice | 48 |
enzymatic activity | 48 |
cell cultures | 48 |
rhus chinensis | 48 |
reactive oxygen | 48 |
infl uence | 48 |
tof tof | 47 |
also known | 47 |
oral administration | 47 |
type ii | 47 |
enzymatic hydrolysis | 47 |
monoclonal antibodies | 47 |
solid support | 47 |
hydrochloric acid | 47 |
specifi city | 47 |
results obtained | 47 |
peptides containing | 47 |
studies showed | 47 |
enzyme activity | 46 |
alcohol consumption | 46 |
acid ceramidase | 46 |
lipid peroxidation | 46 |
previous studies | 46 |
positive bacteria | 46 |
metabolic acidosis | 46 |
cell cycle | 46 |
protein expression | 46 |
insulin resistance | 46 |
room temperature | 46 |
chemical engineering | 46 |
angiotensin ii | 45 |
ionization mass | 45 |
malic acid | 45 |
biological properties | 45 |
crystal structure | 45 |
closely related | 45 |
substrate specificity | 44 |
molecular biology | 44 |
structural analysis | 44 |
high resolution | 44 |
methionine aminopeptidase | 44 |
tandem mass | 44 |
well known | 44 |
free amino | 44 |
highly conserved | 43 |
synthetic peptide | 43 |
cell culture | 43 |
platelet aggregation | 43 |
acid sequences | 43 |
glycan binding | 43 |
dna binding | 43 |
target protein | 43 |
recent studies | 43 |
innate immune | 43 |
also found | 43 |
amino group | 43 |
protein sequence | 42 |
herpes simplex | 42 |
chain fatty | 42 |
three different | 42 |
human health | 42 |
polysialic acid | 42 |
metabolic engineering | 42 |
stem cells | 42 |
aspergillus niger | 42 |
inflammatory cytokines | 42 |
high levels | 42 |
circular dichroism | 41 |
protein interactions | 41 |
molecular mechanisms | 41 |
pseudomonas aeruginosa | 41 |
peptide chain | 41 |
commercially available | 41 |
broad spectrum | 41 |
acid glycan | 41 |
converting enzyme | 41 |
cancer patients | 41 |
medicinal plants | 41 |
recombinant proteins | 40 |
rat liver | 40 |
linolenic acid | 40 |
auf die | 40 |
adipose tissue | 40 |
identifi cation | 40 |
performance liquid | 40 |
oxygen species | 40 |
binding affinity | 40 |
palmitic acid | 40 |
cell penetrating | 40 |
sugar binding | 39 |
therapeutic agents | 39 |
modifi cations | 39 |
monoclonal antibody | 39 |
ms analysis | 39 |
control group | 39 |
ng ml | 39 |
rat brain | 38 |
wide variety | 38 |
metabolic pathways | 38 |
receptor binding | 38 |
first step | 38 |
commonly used | 38 |
wine consumption | 38 |
terminal region | 38 |
gastrointestinal tract | 37 |
functional groups | 37 |
small intestine | 37 |
delivery systems | 37 |
sequence analysis | 37 |
helicobacter pylori | 37 |
sodium bicarbonate | 37 |
cyclic peptide | 37 |
signifi cantly | 37 |
infected cells | 37 |
serum albumin | 37 |
acute respiratory | 37 |
colon cancer | 37 |
type diabetes | 37 |
active peptides | 37 |
amide bond | 37 |
fold higher | 37 |
food intake | 37 |
peptide sequences | 37 |
endoplasmic reticulum | 37 |
betulinic acid | 37 |
glycolylneuraminic acid | 36 |
negative ion | 36 |
peptide bond | 36 |
melanoma cells | 36 |
phenolic acid | 36 |
fermentation process | 36 |
recombinant protein | 36 |
human brain | 36 |
parenteral nutrition | 36 |
methyl ester | 36 |
binding activity | 36 |
chemical structure | 36 |
drug design | 36 |
key role | 36 |
effi ciency | 36 |
acetyl groups | 36 |
technical university | 35 |
mouse model | 35 |
transcription factors | 35 |
punicic acid | 35 |
target cells | 35 |
spike protein | 35 |
cystic fibrosis | 35 |
linoleic acid | 35 |
simplex virus | 35 |
growth rate | 35 |
metal ion | 35 |
transcription factor | 35 |
positively charged | 35 |
affinity chromatography | 35 |
ascorbic acid | 35 |
apn cd | 35 |
flow cytometry | 35 |
tof mass | 35 |
inflammatory response | 35 |
coumaric acid | 35 |
fl ower | 35 |
bacillus subtilis | 35 |
performed using | 35 |
tumor growth | 34 |
ic values | 34 |
essential amino | 34 |
antioxidant capacity | 34 |
immune cells | 34 |
electron microscopy | 34 |
living cells | 34 |
vitro studies | 34 |
previously reported | 34 |
aqueous solution | 34 |
critical role | 34 |
blood glucose | 34 |
takes place | 34 |
human cells | 33 |
protecting groups | 33 |
hydrogen bonding | 33 |
pathogenic bacteria | 33 |
gold nanoparticles | 33 |
pomegranate peel | 33 |
hydrogen bond | 33 |
specifi cally | 33 |
peptide design | 33 |
palmitoylated proteins | 33 |
peptide sequence | 33 |
wistar rats | 33 |
influenza viruses | 33 |
serum levels | 33 |
coiled coil | 33 |
brain barrier | 33 |
experimental data | 33 |
tumor cell | 33 |
peptide analogues | 33 |
mouse brain | 32 |
cryptochlorogenic acid | 32 |
diabetes mellitus | 32 |
ion mode | 32 |
genes encoding | 32 |
rational design | 32 |
plasmodium falciparum | 32 |
bioactive peptides | 32 |
peptides derived | 32 |
large scale | 32 |
significantly increased | 32 |
muscle mass | 32 |
chemical ligation | 32 |
growth hormone | 32 |
conformational analysis | 32 |
autoimmune diseases | 32 |
human breast | 32 |
dietary protein | 32 |
membrane proteins | 32 |
ganglioside gm | 31 |
golgi apparatus | 31 |
binding properties | 31 |
energy metabolism | 31 |
large amounts | 31 |
immune function | 31 |
acid transport | 31 |
inhibitory effects | 31 |
extracellular matrix | 31 |
plasma amino | 31 |
antimicrobial properties | 31 |
nuclear factor | 31 |
analysis revealed | 31 |
bile acids | 31 |
st gal | 31 |
primary structure | 31 |
juice consumption | 31 |
activity relationships | 31 |
proteins involved | 31 |
necrotizing enterocolitis | 31 |
also used | 30 |
small molecule | 30 |
much higher | 30 |
mononuclear cells | 30 |
blood cells | 30 |
glycosylation sites | 30 |
vivo studies | 30 |
metabolic stability | 30 |
synthesis using | 30 |
endothelial cell | 30 |
heart disease | 30 |
multiple sclerosis | 30 |
data suggest | 30 |
surface area | 30 |
free sialic | 30 |
fl uorescent | 30 |
high throughput | 30 |
red blood | 30 |
fusion protein | 30 |
acid concentration | 30 |
peptide fragments | 29 |
physiological conditions | 29 |
din en | 29 |
catalytic activity | 29 |
carbon dioxide | 29 |
deficient mice | 29 |
rats fed | 29 |
new class | 29 |
metabolic syndrome | 29 |
peptide backbone | 29 |
high degree | 29 |
residues tof | 29 |
clinical studies | 29 |
building block | 29 |
sialylated glycans | 29 |
activator protein | 29 |
newly synthesized | 29 |
low molecular | 29 |
helical structure | 29 |
adhesion molecules | 29 |
host cells | 29 |
fl avonoids | 29 |
diffi cult | 29 |
surface plasmon | 29 |
mrna expression | 29 |
fl owers | 29 |
mycophenolic acid | 29 |
innate immunity | 28 |
hydroxyl group | 28 |
major role | 28 |
acid content | 28 |
oxygen transfer | 28 |
bone marrow | 28 |
widely distributed | 28 |
protein palmitoylation | 28 |
bacterial growth | 28 |
molecular basis | 28 |
protective effect | 28 |
bond formation | 28 |
secondary structures | 28 |
linked glycans | 28 |
native chemical | 28 |
antioxidant properties | 28 |
heparan sulfate | 28 |
cultured cells | 28 |
heat shock | 28 |
ion channels | 28 |
layer chromatography | 28 |
sambucus formosananakai | 28 |
eicosapentaenoic acid | 28 |
induced apoptosis | 28 |
significant increase | 28 |
quantitative analysis | 27 |
recombinant human | 27 |
gene therapy | 27 |
medium containing | 27 |
fiber die | 27 |
plasmon resonance | 27 |
using fmoc | 27 |
virus type | 27 |
yeast extract | 27 |
bioactive compounds | 27 |
mass spectrometer | 27 |
model peptides | 27 |
terminal amino | 27 |
also observed | 27 |
directed mutagenesis | 27 |
confi rmed | 27 |
significantly decreased | 27 |
infectious diseases | 27 |
density lipoprotein | 27 |
active sites | 27 |
highly sensitive | 27 |
ankara university | 27 |
crucial role | 27 |
first time | 27 |
antifungal activity | 27 |
blot analysis | 27 |
protein sequences | 27 |
dendritic cells | 27 |
ethanol extract | 27 |
peptide library | 26 |
therapeutic potential | 26 |
phytochemical constituents | 26 |
human body | 26 |
ern hrung | 26 |
disulfide bridges | 26 |
human igg | 26 |
small amounts | 26 |
antimicrobial agents | 26 |
peptide ligands | 26 |
chemical properties | 26 |
potent inhibitors | 26 |
results suggested | 26 |
anticancer drugs | 26 |
terminal part | 26 |
may contribute | 26 |
bovine serum | 26 |
coupling reagents | 26 |
glycan structures | 26 |
physicochemical properties | 26 |
colorectal cancer | 26 |
natural amino | 26 |
antimicrobial activities | 26 |
biological processes | 26 |
magnetic resonance | 26 |
factors affecting | 26 |
related compounds | 26 |
ic value | 26 |
virtual screening | 26 |
critically ill | 26 |
biological functions | 26 |
carboxylic acids | 26 |
new method | 26 |
high affi | 26 |
short peptides | 26 |
animal model | 25 |
may lead | 25 |
cell type | 25 |
conformational changes | 25 |
potential therapeutic | 25 |
culture medium | 25 |
phage display | 25 |
salmonella typhimurium | 25 |
neurodegenerative diseases | 25 |
null mice | 25 |
base balance | 25 |
glucose metabolism | 25 |
may play | 25 |
growth inhibition | 25 |
hydroxyl groups | 25 |
weight loss | 25 |
taken together | 25 |
normal human | 25 |
vascular endothelial | 25 |
plant species | 25 |
membrane protein | 25 |
signaling pathways | 25 |
mechanical properties | 25 |
free radicals | 25 |
free radical | 25 |
terminal domain | 25 |
blood vessels | 25 |
carboxyl group | 25 |
structural features | 25 |
molecular recognition | 25 |
sh domain | 25 |
based therapeutics | 25 |
two groups | 25 |
preliminary results | 25 |
nmda receptor | 25 |
containing peptides | 25 |
fatty acyl | 25 |
enzymes involved | 25 |
penetrating peptide | 25 |
exchange chromatography | 25 |
flos lonicerae | 25 |
high yield | 25 |
native peptide | 25 |
another study | 25 |
protein folding | 25 |
cell receptor | 25 |
cancer treatment | 24 |
years ago | 24 |
open reading | 24 |
low concentrations | 24 |
gene encoding | 24 |
least two | 24 |
transgenic mice | 24 |
total synthesis | 24 |
drug resistance | 24 |
clinical trial | 24 |
human milk | 24 |
signal peptide | 24 |
peptide derivatives | 24 |
disulfide bonds | 24 |
therapeutic target | 24 |
cognitive decline | 24 |
also showed | 24 |
carbonic anhydrase | 24 |
structural determination | 24 |
previously described | 24 |
peripheral blood | 24 |
high concentrations | 24 |
immunodeficiency virus | 24 |
unnatural amino | 24 |
two types | 24 |
acid bacteria | 24 |
last years | 24 |
results indicated | 24 |
health benefits | 24 |
genes involved | 24 |
rich peptides | 24 |
significantly reduced | 24 |
opioid receptor | 24 |
candida albicans | 24 |
genomic dna | 23 |
boronic acid | 23 |
will also | 23 |
low levels | 23 |
peptide bonds | 23 |
neochlorogenic acid | 23 |
highly specific | 23 |
aqueous solutions | 23 |
enveloped viruses | 23 |
hydrogen peroxide | 23 |
investigated using | 23 |
new analogues | 23 |
cinnamic acid | 23 |
animal viruses | 23 |
receptor antagonist | 23 |
dynamics simulations | 23 |
hydrogen bonds | 23 |
neuraminic acid | 23 |
fi brils | 23 |
amino groups | 23 |
method using | 23 |
protecting group | 23 |
oic acid | 23 |
protein structure | 23 |
analysis using | 23 |
studies revealed | 23 |
using different | 23 |
anticancer activity | 23 |
opioid receptors | 23 |
highly potent | 23 |
ganglioside biosynthesis | 23 |
calcium hydroxide | 23 |
phase method | 23 |
acid constituents | 23 |
studies using | 23 |
ethanol production | 23 |
culture conditions | 23 |
peptide nucleic | 23 |
stationary phase | 23 |
ang ii | 23 |
smooth muscle | 23 |
highly selective | 23 |
estrogen receptor | 23 |
natural sources | 23 |
cardiovascular disease | 23 |
biological evaluation | 22 |
enzyme inhibitors | 22 |
formic acid | 22 |
lactic acidosis | 22 |
delivery system | 22 |
cell viability | 22 |
times higher | 22 |
commonly found | 22 |
intrinsically disordered | 22 |
several different | 22 |
red wines | 22 |
food industry | 22 |
glutamate receptors | 22 |
peel extract | 22 |
human plasma | 22 |
several studies | 22 |
high molecular | 22 |
tyrosine kinase | 22 |
effi cacy | 22 |
bei der | 22 |
artifi cial | 22 |
oxide synthase | 22 |
physiological ph | 22 |
bacterial cell | 22 |
defi ned | 22 |
proteomic analysis | 22 |
bacterial species | 22 |
electrospray ionization | 22 |
ca i | 22 |
pharmaceutical industry | 22 |
plant extracts | 22 |
acid concentrations | 22 |
high level | 22 |
superoxide dismutase | 22 |
peptide libraries | 22 |
fusion proteins | 22 |
cell lung | 22 |
apn inhibitors | 22 |
plaque formation | 22 |
wheat straw | 22 |
lipid bilayer | 22 |
respiratory syndrome | 22 |
st sia | 22 |
secondary metabolite | 22 |
synthesized using | 22 |
human skin | 22 |
outer membrane | 22 |
resistant staphylococcus | 22 |
see section | 22 |
target proteins | 22 |
ferulic acid | 22 |
potent inhibitor | 22 |
negative charge | 21 |
steric block | 21 |
fold increase | 21 |
pomegranate fl | 21 |
oleic acid | 21 |
significant effect | 21 |
transition state | 21 |
spike glycoprotein | 21 |
present paper | 21 |
drug development | 21 |
like receptor | 21 |
western blot | 21 |
sample preparation | 21 |
recent study | 21 |
thin layer | 21 |
acid load | 21 |
recently reported | 21 |
complete reduction | 21 |
interaction chromatography | 21 |
cancer cachexia | 21 |
determine whether | 21 |
molecular weights | 21 |
functional analysis | 21 |
polymalic acid | 21 |
data indicate | 21 |
cell division | 21 |
activity towards | 21 |
allowed us | 21 |
determined using | 21 |
helical conformation | 21 |
peptide conjugates | 21 |
structural information | 21 |
brain development | 21 |
fmoc tbu | 21 |
rat plasma | 21 |
plasmid dna | 21 |
neuronal cells | 21 |
solid state | 21 |
human genome | 21 |
biosynthetic pathway | 21 |
gram negative | 21 |
radical scavenging | 21 |
middle east | 21 |
structural studies | 21 |
beneficial effects | 21 |
nmr spectra | 21 |
early stages | 21 |
diabetic rats | 21 |
pichia pastoris | 21 |
wound healing | 21 |
dna damage | 21 |
clinical outcomes | 21 |
ill patients | 21 |
ray diffraction | 21 |
gene delivery | 21 |
gastric cancer | 21 |
benzoic acid | 21 |
human immunodeficiency | 21 |
acid side | 21 |
binding capacity | 21 |
charged residues | 20 |
eukaryotic cells | 20 |
translational modifications | 20 |
pulmonary diseases | 20 |
ovarian cancer | 20 |
also investigated | 20 |
enzymatic degradation | 20 |
mrna levels | 20 |
results will | 20 |
reading frame | 20 |
successfully applied | 20 |
prion protein | 20 |
terminal fragment | 20 |
medium composition | 20 |
high performance | 20 |
tertiary structure | 20 |
molecular species | 20 |
cell differentiation | 20 |
polyphenolic compounds | 20 |
water molecules | 20 |
disulfide bond | 20 |
chinese hamster | 20 |
drug target | 20 |
based approach | 20 |
disease virus | 20 |
united states | 20 |
synthesized peptides | 20 |
control mice | 20 |
plant growth | 20 |
molecular mechanism | 20 |
anticancer drug | 20 |
chemical stability | 20 |
tumor suppressor | 20 |
reporter gene | 20 |
two main | 20 |
green tea | 20 |
coupled receptors | 20 |
drug candidates | 20 |
glucose uptake | 20 |
gm activator | 20 |
cultured human | 20 |
kg body | 20 |
will present | 20 |
hela cells | 20 |
respiratory distress | 20 |
crystal structures | 20 |
molecular docking | 20 |
human colon | 20 |
essential oils | 20 |
protein design | 20 |
inflammatory responses | 20 |
cell epitopes | 20 |
fi ed | 20 |
also play | 20 |
aromatic amino | 20 |
unsaturated fatty | 20 |
adhesion molecule | 20 |
disulfide bridge | 20 |
chain length | 20 |
enzymatic synthesis | 20 |
bacterial strains | 20 |
capillary electrophoresis | 20 |
human melanoma | 20 |
structure activity | 19 |
serine protease | 19 |
renal tubular | 19 |
essential role | 19 |
lung injury | 19 |
viral proteins | 19 |
soybean oil | 19 |
ion exchange | 19 |
induces apoptosis | 19 |
dimensional structure | 19 |
chemical composition | 19 |
intensive care | 19 |
insulin sensitivity | 19 |
degrading enzymes | 19 |
ph values | 19 |
camphoric acid | 19 |
calcium carbonate | 19 |
high temperature | 19 |
secondary metabolism | 19 |
older people | 19 |
glucose levels | 19 |
muscle cells | 19 |
disordered proteins | 19 |
rna viruses | 19 |
model systems | 19 |
dna sequences | 19 |
two peptides | 19 |
traditional chinese | 19 |
recent advances | 19 |
product formation | 19 |
hamster ovary | 19 |
mg gfw | 19 |
interfering rna | 19 |
intestinal tract | 19 |
gene silencing | 19 |
cysteine residues | 19 |
serine proteases | 19 |
propionic acid | 19 |
cytokine production | 19 |
ethyl acetate | 19 |
acid glycans | 19 |
positive ion | 19 |
nmda receptors | 19 |
model system | 19 |
hydrophobic interaction | 19 |
free fatty | 19 |
human diseases | 19 |
complex formation | 19 |
expression levels | 19 |
intestinal mucosa | 19 |
obtained using | 19 |
nuclear magnetic | 19 |
broad range | 19 |
cell migration | 19 |
cell surfaces | 19 |
environmental conditions | 19 |
class i | 19 |
arabidopsis thaliana | 19 |
data sets | 19 |
research centre | 19 |
possible role | 19 |
fi eld | 19 |
potent anti | 19 |
previous study | 19 |
particle size | 19 |
antibacterial properties | 19 |
electrostatic interactions | 19 |
intrinsic disorder | 19 |
avian influenza | 19 |
ligand binding | 19 |
hepatocellular carcinoma | 19 |
full length | 19 |
chemical structures | 19 |
fi nal | 19 |
flight mass | 19 |
evidence suggests | 19 |
catalytic domain | 19 |
cd spectroscopy | 19 |
maldi mass | 19 |
endothelial growth | 19 |
thermal stability | 19 |
two distinct | 19 |
gas chromatography | 19 |
cell survival | 19 |
showed high | 19 |
translational modification | 19 |
septic shock | 19 |
membrane fusion | 19 |
insulin secretion | 18 |
body composition | 18 |
model peptide | 18 |
acidic ph | 18 |
ganglioside gd | 18 |
ser thr | 18 |
bile acid | 18 |
umbilical vein | 18 |
van der | 18 |
plasma glucose | 18 |
gram positive | 18 |
tof synthesis | 18 |
hyaluronic acid | 18 |
terminal sialic | 18 |
activated protein | 18 |
kaurenoic acid | 18 |
cmah gene | 18 |
significant differences | 18 |
gene products | 18 |
various types | 18 |
spectrometric analysis | 18 |
computational methods | 18 |
natural killer | 18 |
acdase activity | 18 |
throughput screening | 18 |
acid inhibits | 18 |
carcinoma cells | 18 |
cho cells | 18 |
protein interaction | 18 |
adenylate cyclase | 18 |
blood plasma | 18 |
high content | 18 |
low ph | 18 |
distress syndrome | 18 |
streptococcus pneumoniae | 18 |
human diet | 18 |
com scientificreports | 18 |
insulin signaling | 18 |
cells using | 18 |
organic acid | 18 |
last decade | 18 |
may occur | 18 |
nitrogen sources | 18 |
antimicrobial effects | 18 |
retention time | 18 |
triple helix | 18 |
important roles | 18 |
protein levels | 18 |
life sciences | 18 |
cell apoptosis | 18 |
peritoneal macrophages | 18 |
phase ii | 18 |
binding studies | 18 |
cell epitope | 18 |
enteral nutrition | 18 |
protein kinases | 18 |
reductive amination | 18 |
protein production | 18 |
specific activity | 18 |
viral infection | 18 |
kda protein | 18 |
powerful tool | 18 |
different concentrations | 18 |
blood coagulation | 18 |
natural product | 18 |
different cell | 18 |
quantum dots | 18 |
growth factors | 18 |
bacterial infections | 18 |
diabetic patients | 18 |
flow rate | 18 |
drug administration | 18 |
may provide | 18 |
gel filtration | 18 |
current study | 18 |
expression vector | 18 |
hepg cells | 18 |
may result | 18 |
acute lung | 18 |
enzyme production | 18 |
group ii | 18 |
western blotting | 18 |
may cause | 18 |
cytotoxic activity | 18 |
acid analysis | 18 |
fermented juice | 18 |
polypeptide chain | 18 |
biological function | 18 |
natural compounds | 18 |
peptide chemistry | 18 |
human prostate | 18 |
mycobacterium tuberculosis | 18 |
rich protein | 18 |
fluorescence microscopy | 18 |
related proteins | 18 |
lipid metabolism | 18 |
useful tools | 17 |
tissue engineering | 17 |
glucuronic acid | 17 |
peptide derived | 17 |
cell signaling | 17 |
organic solvents | 17 |
receptor antagonists | 17 |
per se | 17 |
column chromatography | 17 |
small peptides | 17 |
four different | 17 |
great potential | 17 |
infl ammatory | 17 |
authors declare | 17 |
studied using | 17 |
arginine residues | 17 |
secreted phospholipase | 17 |
bestimmung der | 17 |
surface receptors | 17 |
scavenging activity | 17 |
hplc analysis | 17 |
national institute | 17 |
monte carlo | 17 |
potent antioxidant | 17 |
medicinal chemistry | 17 |
cellular membranes | 17 |
data obtained | 17 |
carbon sources | 17 |
respiratory tract | 17 |
binding affi | 17 |
protein binding | 17 |
small interfering | 17 |
similar results | 17 |
linked glycosylation | 17 |
recently developed | 17 |
pyruvate dehydrogenase | 17 |
brain gangliosides | 17 |
acid peptide | 17 |
active compounds | 17 |
high purity | 17 |
conformational change | 17 |
pharmacological activity | 17 |
inflammatory mediators | 17 |
organic chemistry | 17 |
small number | 17 |
relatively high | 17 |
expression level | 17 |
random coil | 17 |
per day | 17 |
poorly understood | 17 |
promising results | 17 |
severe acute | 17 |
rna interference | 17 |
chemical groups | 17 |
virus attachment | 17 |
pharmacological properties | 17 |
factor receptor | 17 |
also able | 17 |
body fat | 17 |
biological effects | 17 |
acid oxidation | 17 |
limited number | 17 |
selective inhibitors | 17 |
group i | 17 |
gene transcription | 17 |
short peptide | 17 |
therapeutic applications | 17 |
agrobacterium rhizogenes | 17 |
antiproliferative activity | 17 |
intracellular trafficking | 17 |
brain tissue | 17 |
batch phase | 17 |
stranded rna | 17 |
cationic amino | 17 |
derived peptides | 17 |
sea urchin | 17 |
maldi ms | 17 |
intracellular delivery | 17 |
analysis showed | 17 |
steady state | 17 |
phosphate buffer | 17 |
low doses | 17 |
bile salts | 17 |
great interest | 17 |
kidney disease | 17 |
hydrophobic interactions | 17 |
great apes | 17 |
programmed cell | 17 |
cells via | 17 |
serum samples | 17 |
epithelial cell | 17 |
extract inhibited | 17 |
highly expressed | 17 |
least one | 17 |
two new | 17 |
mammary gland | 17 |
sequence similarity | 17 |
research group | 17 |
sole carbon | 17 |
sirna delivery | 17 |
inflammatory cells | 16 |
controlled trial | 16 |
glycan chains | 16 |
endosomal escape | 16 |
transmembrane protein | 16 |
nutrition nr | 16 |
high pressure | 16 |
binding motif | 16 |
lipid rafts | 16 |
secretory phospholipase | 16 |
chondroitin sulfate | 16 |
acid hydrolysis | 16 |
much less | 16 |
public health | 16 |
dna sequence | 16 |
ordered proteins | 16 |
central role | 16 |
glycan analysis | 16 |
nutritional status | 16 |
high activity | 16 |
muscular dystrophy | 16 |
inflammatory diseases | 16 |
silica gel | 16 |
intestinal bacteria | 16 |
ph range | 16 |
alkaline ceramidase | 16 |
immunomodulatory properties | 16 |
linear peptide | 16 |
membrane permeability | 16 |
glucose level | 16 |
plasma levels | 16 |
acetyl group | 16 |
metabolic pathway | 16 |
immunomodulatory activity | 16 |
tumor targeting | 16 |
mass transfer | 16 |
tissue sections | 16 |
base theories | 16 |
nmr studies | 16 |
early stage | 16 |
aqueous extract | 16 |
formosananakai extract | 16 |
gm gangliosidosis | 16 |
blood mononuclear | 16 |
creative commons | 16 |
signal sequence | 16 |
structural units | 16 |
shock proteins | 16 |
ex vivo | 16 |
time point | 16 |
expressed protein | 16 |
sambucus nigra | 16 |
cancer development | 16 |
reverse transcriptase | 16 |
fatty acylation | 16 |
proteolytic activity | 16 |
new approach | 16 |
fl ammation | 16 |
hydrophobic residues | 16 |
sequence information | 16 |
fat diet | 16 |
dissolved oxygen | 16 |
studies demonstrated | 16 |
much lower | 16 |
mast cells | 16 |
vein endothelial | 16 |
chronic kidney | 16 |
receptor agonist | 16 |
structurally related | 16 |
light scattering | 16 |
ionic liquid | 16 |
also demonstrated | 16 |
dry weight | 16 |
sequence homology | 16 |
human coronavirus | 16 |
antibacterial activities | 16 |
structural basis | 16 |
nutritive value | 16 |
gastric mucosa | 16 |
guinea pigs | 16 |
auf den | 16 |
based method | 16 |
profi le | 16 |
splice correction | 16 |
will describe | 16 |
protease activity | 16 |
conformational properties | 16 |
two novel | 16 |
antisense oligonucleotides | 16 |
reversed phase | 16 |
divalent cations | 16 |
microwave assisted | 16 |
conformational studies | 16 |
structural changes | 16 |
ion mobility | 16 |
end products | 16 |
signaling pathway | 16 |
will allow | 16 |
net charge | 16 |
may represent | 16 |
chromatographic separation | 16 |
virus yield | 16 |
neuronal cell | 16 |
coronary heart | 15 |
biological samples | 15 |
relatively low | 15 |
network structure | 15 |
chain reaction | 15 |
single molecule | 15 |
energy transfer | 15 |
anticancer effects | 15 |
will provide | 15 |
stem cell | 15 |
different stages | 15 |
oleanolic acid | 15 |
viral rna | 15 |
acid conjugates | 15 |
olive oil | 15 |
sinapinic acid | 15 |
knockout mice | 15 |
rnase iii | 15 |
cell invasion | 15 |
brain regions | 15 |
viral genome | 15 |
protein concentration | 15 |
egg yolk | 15 |
salivary glands | 15 |
replacement therapy | 15 |
cell monolayer | 15 |
binding peptides | 15 |
dna replication | 15 |
significantly lower | 15 |
novel peptide | 15 |
different methods | 15 |
binding domains | 15 |
carbon atoms | 15 |
mucosal surfaces | 15 |
situ hybridization | 15 |
gives rise | 15 |
molecular modeling | 15 |
proteinogenic amino | 15 |
experimental conditions | 15 |
compounds may | 15 |
higher concentrations | 15 |
myocardial infarction | 15 |
trypsin inhibitor | 15 |
three types | 15 |
better understanding | 15 |
plasma samples | 15 |
genetic engineering | 15 |
energy expenditure | 15 |
phase extraction | 15 |
tat peptide | 15 |
enzyme activities | 15 |
aroc values | 15 |
containing two | 15 |
wine phenolics | 15 |
even though | 15 |
gene cluster | 15 |
pharmacological activities | 15 |
pathological conditions | 15 |
free energy | 15 |
reaction mixture | 15 |
single cell | 15 |
protein coupled | 15 |
dilution rate | 15 |
filamentous fungi | 15 |
beitrag zur | 15 |
plant cell | 15 |
alternative splicing | 15 |
cell function | 15 |
molecular cloning | 15 |
two strains | 15 |
methyl esters | 15 |
cysteine residue | 15 |
differential expression | 15 |
polyacrylamide gel | 15 |
cell density | 15 |
key enzyme | 15 |
low micromolar | 15 |
aminopeptidase inhibitors | 15 |
dental caries | 15 |
structural diversity | 15 |
significant role | 15 |
different conditions | 15 |
peptide binding | 15 |
degradation products | 15 |
highly efficient | 15 |
different species | 15 |
coupling reaction | 15 |
acid levels | 15 |
structural data | 15 |
using various | 15 |
point mutations | 15 |
tryptic peptides | 15 |
amyloid fibrils | 15 |
dietary supplementation | 15 |
chemically synthesized | 15 |
protease inhibitors | 15 |
blood flow | 15 |
ring opening | 15 |
nanomolar range | 15 |
human cancer | 15 |
particular interest | 15 |
dairy products | 15 |
protein molecules | 15 |
fi cient | 15 |
assay using | 15 |
transmembrane domain | 15 |
internal standard | 15 |
male rats | 15 |
polymerase chain | 15 |
metabolic flux | 15 |
chain amino | 15 |
mammalian cell | 15 |
double bond | 15 |
three major | 15 |
comparative study | 15 |
three dimensional | 15 |
well established | 15 |
biomedical applications | 15 |
effi ciently | 15 |
pomegranate polyphenols | 15 |
older adults | 15 |
cycle arrest | 15 |
mouse models | 15 |
docosahexaenoic acid | 15 |
mass spectra | 15 |
medicinal plant | 15 |
angiotensin converting | 15 |
various biological | 15 |
new drugs | 15 |
magnetic nanoparticles | 14 |
protein turnover | 14 |
human umbilical | 14 |
aminobutyric acid | 14 |
clinical use | 14 |
cantly inhibited | 14 |
ms method | 14 |
significant difference | 14 |
polyethylene glycol | 14 |
chronic diseases | 14 |
fl ow | 14 |
confi guration | 14 |
calf thymus | 14 |
pancreatic cancer | 14 |
proteolytic degradation | 14 |
various diseases | 14 |
insect cells | 14 |
different forms | 14 |
acid compositions | 14 |
antitumor activity | 14 |
risk factors | 14 |
potential application | 14 |
studies will | 14 |
positive charge | 14 |
photodynamic therapy | 14 |
proteolytic stability | 14 |
aqueous media | 14 |
living organisms | 14 |
studies concerning | 14 |
higher activity | 14 |
specific binding | 14 |
directly involved | 14 |
saturated fatty | 14 |
infectious bronchitis | 14 |
acylated proteins | 14 |
highly active | 14 |
also reported | 14 |
covalently linked | 14 |
located within | 14 |
primary protein | 14 |
idps idprs | 14 |
proline residues | 14 |
specific expression | 14 |
mucosal cell | 14 |
trifluoroacetic acid | 14 |
pulmonary disease | 14 |
liver disease | 14 |
large intestine | 14 |
human cell | 14 |
using high | 14 |
peptide substrates | 14 |
alternative oxidase | 14 |
cell activation | 14 |
higher affinity | 14 |
time points | 14 |
sequence identity | 14 |
drug release | 14 |
blood samples | 14 |
structural analogues | 14 |
lesser extent | 14 |
also inhibited | 14 |
molecular level | 14 |
life cycle | 14 |
cleavage site | 14 |
protein level | 14 |
peel extracts | 14 |
binding mode | 14 |
dna polymerase | 14 |
nontransformed roots | 14 |
targeted delivery | 14 |
activating factor | 14 |
acid hydroxylase | 14 |
body mass | 14 |
hospital stay | 14 |
linked oligosaccharides | 14 |
extensively studied | 14 |
positive cells | 14 |
peptide interactions | 14 |
fi ndings | 14 |
key enzymes | 14 |
click reaction | 14 |
series gangliosides | 14 |
sachs disease | 14 |
binding assay | 14 |
brush border | 14 |
next step | 14 |
lemon juice | 14 |
recently shown | 14 |
human liver | 14 |
results demonstrated | 14 |
obtained results | 14 |
lysine residues | 14 |
heart rate | 14 |
nontransgenic roots | 14 |
contact time | 14 |
expression system | 14 |
spectrometry analysis | 14 |
human tissues | 14 |
steric hindrance | 14 |
take place | 14 |
gd synthase | 14 |
functional group | 14 |
significant amounts | 14 |
homologous recombination | 14 |
protein fragments | 14 |
protein amino | 14 |
well plate | 14 |
single amino | 14 |
dna gyrase | 14 |
peptide analogs | 14 |
cytoplasmic tail | 14 |
clinical applications | 14 |
beneficial effect | 14 |
environmental factors | 14 |
class ii | 14 |
gastric acid | 14 |
another important | 14 |
adaptive immunity | 14 |
give rise | 14 |
extract inhibits | 14 |
rich region | 14 |
acid functionalized | 14 |
great importance | 14 |
among others | 14 |
cardiovascular diseases | 14 |
hemolytic activity | 14 |
cos cells | 14 |
financial support | 14 |
dietary fat | 14 |
neutral ph | 14 |
real time | 14 |
coding region | 14 |
target cell | 14 |
maldi analysis | 14 |
also studied | 14 |
glutamate release | 14 |
capsid proteins | 14 |
intestinal absorption | 14 |
matrix metalloproteinases | 14 |
experiments showed | 14 |
bene fi | 14 |
egg white | 14 |
focused teaching | 13 |
final product | 13 |
significant decrease | 13 |
nutrition rev | 13 |
may explain | 13 |
kinetic parameters | 13 |
chemical modifications | 13 |
bacillus anthracis | 13 |
per year | 13 |
lactate dehydrogenase | 13 |
block oligonucleotides | 13 |
surface antigen | 13 |
antibody recognition | 13 |
many cases | 13 |
cd spectra | 13 |
cationic antimicrobial | 13 |
side reactions | 13 |
conformational preferences | 13 |
autosomal recessive | 13 |
peptide dendrimers | 13 |
two decades | 13 |
derived peptide | 13 |
acid supplementation | 13 |
listeria monocytogenes | 13 |
inclusion bodies | 13 |
fmoc chemistry | 13 |
containing amino | 13 |
charged amino | 13 |
recent developments | 13 |
tubular acidosis | 13 |
gene transfer | 13 |
heavy metal | 13 |
research institute | 13 |
data acquisition | 13 |
associated protein | 13 |
biosynthetic pathways | 13 |
reactive protein | 13 |
pharmacokinetic study | 13 |
purified using | 13 |
cdna library | 13 |
melanoma cell | 13 |
long chain | 13 |
sequence motifs | 13 |
methyl gallate | 13 |
historical development | 13 |
previous reports | 13 |
zeta potential | 13 |
gene family | 13 |
metal binding | 13 |
data set | 13 |
using standard | 13 |
aminoisobutyric acid | 13 |
infrared spectroscopy | 13 |
translation initiation | 13 |
angiotensin i | 13 |
recently described | 13 |
cytotoxic effects | 13 |
small cell | 13 |
yeast cells | 13 |
batch cultures | 13 |
statistically significant | 13 |
functionalized gold | 13 |
ligand interactions | 13 |
glycosylation site | 13 |
northern blot | 13 |
mass spectroscopy | 13 |
using maldi | 13 |
antioxidant activities | 13 |
total number | 13 |
cerebral cortex | 13 |
carrier protein | 13 |
protein function | 13 |
gene clusters | 13 |
vitro assays | 13 |
synthetic derivatives | 13 |
protective effects | 13 |
hydrophilic interaction | 13 |
dipolar cycloaddition | 13 |
new generation | 13 |
acid biosynthesis | 13 |
primary nec | 13 |
dna fragmentation | 13 |
another approach | 13 |
affi nities | 13 |
cells may | 13 |
fermentation broth | 13 |
aromatic residues | 13 |
chemical modification | 13 |
sugar chains | 13 |
energy intake | 13 |
experimental details | 13 |
clinical isolates | 13 |
protein engineering | 13 |
gc ms | 13 |
cryptococcus neoformans | 13 |
liquid matrices | 13 |
drug targets | 13 |
nuclear antigen | 13 |
previous work | 13 |
biological membranes | 13 |
peptide containing | 13 |
lignocellulosic biomass | 13 |
currently used | 13 |
lead compounds | 13 |
proteolytic enzymes | 13 |
active transport | 13 |
peripheral tissues | 13 |
micromolar range | 13 |
transgenic plants | 13 |
protein tyrosine | 13 |
digestive tract | 13 |
acidic conditions | 13 |
covalently bound | 13 |
fruit peel | 13 |
primary sequence | 13 |
phase i | 13 |
virus replication | 13 |
male wistar | 13 |
uorescence spectroscopy | 13 |
alcohol intake | 13 |
blood group | 13 |
like peptide | 13 |
mice lacking | 13 |
low toxicity | 13 |
receptor activation | 13 |
two major | 13 |
reducing power | 13 |
mg protein | 13 |
functional properties | 13 |
cell extracts | 13 |
results demonstrate | 13 |
patients undergoing | 13 |
starting point | 13 |
white wines | 13 |
protein complexes | 13 |
scale production | 13 |
protein ligation | 13 |
basic amino | 13 |
enzymatic digestion | 13 |
pomegranate seeds | 13 |
presentation will | 13 |
high quality | 13 |
posttranslational modification | 13 |
natural peptides | 13 |
modified peptides | 13 |
metabolite production | 13 |
graduate school | 13 |
binding assays | 13 |
based assay | 13 |
viral infections | 13 |
ion trap | 13 |
enzymatic activities | 13 |
aspartic acids | 13 |
using two | 13 |
acid transporter | 13 |
human platelet | 13 |
lipid bilayers | 13 |
metabolic alkalosis | 13 |
like activity | 13 |
pure form | 13 |
findings suggest | 13 |
sandhoff disease | 13 |
physiological processes | 13 |
animal studies | 13 |
structural properties | 13 |
prepared using | 13 |
zur bestimmung | 13 |
pomegranate rind | 13 |
lipid mediators | 13 |
peptide arrays | 13 |
analgesic effect | 13 |
normal cells | 13 |
significantly higher | 13 |
anaerobic conditions | 13 |
rgd sequence | 13 |
major histocompatibility | 13 |
inflammatory activity | 13 |
wheat bran | 13 |
mouth disease | 13 |
molecular modelling | 13 |
structure analysis | 13 |
dietary sources | 13 |
assisted solid | 12 |
host defense | 12 |
proton pump | 12 |
cancer therapies | 12 |
specific amino | 12 |
phylogenetic analysis | 12 |
sh domains | 12 |
cell biology | 12 |
relationship studies | 12 |
surface sialic | 12 |
maackia amurensis | 12 |
designed based | 12 |
acyl donor | 12 |
moderate alcohol | 12 |
dietary acid | 12 |
synthetic strategy | 12 |
roots compared | 12 |
one study | 12 |
hydrophobic amino | 12 |
pfeifer barbosa | 12 |
terminal peptide | 12 |
taking advantage | 12 |
adverse effects | 12 |
major components | 12 |
syndrome coronavirus | 12 |
activity studies | 12 |
positive control | 12 |
conventional methods | 12 |
experimental results | 12 |
continuous epitopes | 12 |
human blood | 12 |
membrane surface | 12 |
reaction times | 12 |
causative agent | 12 |
inflammatory processes | 12 |
may induce | 12 |
raw material | 12 |
fl ammatory | 12 |
contains two | 12 |
genome sequence | 12 |
base models | 12 |
glycolic acid | 12 |
negative control | 12 |
different kinds | 12 |
cholera toxin | 12 |
competitive inhibitor | 12 |
high selectivity | 12 |
also shown | 12 |
pomegranate juices | 12 |
may increase | 12 |
subcellular localization | 12 |
less likely | 12 |
soluble protein | 12 |
glycans released | 12 |
ciliary activity | 12 |
life span | 12 |
studies indicate | 12 |
significant change | 12 |
blood cell | 12 |
many years | 12 |
large amount | 12 |
viral vectors | 12 |
novel approach | 12 |
gene product | 12 |
new type | 12 |
toxic effects | 12 |
growth conditions | 12 |
rich pomegranate | 12 |
posttranslational modifications | 12 |
cell activity | 12 |
cell entry | 12 |
probably due | 12 |
pharmacokinetic properties | 12 |
peptide conformation | 12 |
head groups | 12 |
gluconic acid | 12 |
quality control | 12 |
chemical methods | 12 |
viral nucleic | 12 |
cyclic nucleotide | 12 |
kg ha | 12 |
university students | 12 |
carbohydrate metabolism | 12 |
antibacterial agents | 12 |
aided design | 12 |
transport system | 12 |
linear peptides | 12 |
new therapeutic | 12 |
often used | 12 |
high blood | 12 |
structure elucidation | 12 |
urea cycle | 12 |
schwann cells | 12 |
data show | 12 |
structure determination | 12 |
amyloid formation | 12 |
base chemistry | 12 |
crude extract | 12 |
gastric juice | 12 |
neutral ceramidase | 12 |
gut microbiota | 12 |
xenopus oocytes | 12 |
seed extract | 12 |
metabolic fluxes | 12 |
size exclusion | 12 |
terminal residues | 12 |
drinking water | 12 |
mechanisms involved | 12 |
time course | 12 |
microwave irradiation | 12 |
insulin receptor | 12 |
increased significantly | 12 |
alcoholic beverages | 12 |
large part | 12 |
surface expression | 12 |
human erythrocytes | 12 |
new insights | 12 |
fatty liver | 12 |
receptor subtype | 12 |
acute lymphoblastic | 12 |
energy source | 12 |
neutral amino | 12 |
mediated delivery | 12 |
systemic inflammatory | 12 |
different strategies | 12 |
compounds containing | 12 |
prediction method | 12 |
lymph nodes | 12 |
neuraminidase treatment | 12 |
carcinogenic cells | 12 |
synaptic plasticity | 12 |
tof analysis | 12 |
imaging mass | 12 |
physical properties | 12 |
serum glycoproteins | 12 |
ray crystallography | 12 |
mitochondrial membrane | 12 |
methods used | 12 |
guinea pig | 12 |
mannose residues | 12 |
untersuchungen fiber | 12 |
thiol groups | 12 |
fl uenza | 12 |
biological roles | 12 |
amadori products | 12 |
ms spectra | 12 |
inhibitory concentration | 12 |
hydrophobic core | 12 |
peptide structure | 12 |
neisseria meningitidis | 12 |
casd gene | 12 |
web server | 12 |
isolated rat | 12 |
trichogin ga | 12 |
glutathione peroxidase | 12 |
ower extract | 12 |
human intestinal | 12 |
results revealed | 12 |
fruit rind | 12 |
food additives | 12 |
studies suggest | 12 |
acid etching | 12 |
light chain | 12 |
new zealand | 12 |
virus particles | 12 |
physiological role | 12 |
growing interest | 12 |
juice polyphenols | 12 |
peptide drugs | 12 |
like protein | 12 |
stranded dna | 12 |
vegetable oils | 12 |
will focus | 12 |
chronic inflammation | 12 |
functional food | 12 |
glycan release | 12 |
nude mice | 12 |
salt concentration | 12 |
protein content | 12 |
therapeutic approach | 12 |
peptides will | 12 |
normal tissues | 12 |
da release | 12 |
anion exchange | 12 |
lonicerae preparations | 12 |
bind sialic | 12 |
acid analogues | 12 |
glucose tolerance | 12 |
peptide inhibitors | 12 |
antigen presentation | 12 |
kinetic studies | 12 |
various cell | 12 |
risk factor | 12 |
three groups | 12 |
human neutrophils | 12 |
like particles | 12 |
also tested | 12 |
aureobasidium pullulans | 12 |
first isolated | 12 |
terminal sequence | 12 |
monomeric sugars | 12 |
membrane phospholipids | 12 |
rna polymerase | 12 |
identi fi | 12 |
ga iv | 12 |
treated mice | 12 |
peptides based | 12 |
reaction conditions | 12 |
experimental group | 12 |
three times | 12 |
parietal cells | 12 |
two steps | 12 |
proteins using | 12 |
covalent attachment | 12 |
evening primrose | 12 |
dependent kinase | 12 |
higher concentration | 12 |
hydrolyzable tannins | 12 |
matrix proteins | 12 |
best results | 12 |
frequently used | 12 |
molar ratio | 12 |
surface receptor | 12 |
glycyrrhizic acid | 12 |
antimicrobial effect | 12 |
ionization time | 12 |
ovary cells | 12 |
dynamic light | 12 |
vaccinia virus | 12 |
human growth | 12 |
fluorescence spectroscopy | 12 |
adult rats | 12 |
ionic liquids | 12 |
initiation factor | 12 |
human lung | 12 |
volatile fatty | 12 |
rat model | 12 |
lipid composition | 12 |
dengue virus | 12 |
taurine depletion | 12 |
two amino | 12 |
double mutant | 11 |
showed higher | 11 |
conformational space | 11 |
severe sepsis | 11 |
releasing hormone | 11 |
ds brain | 11 |
die wirkung | 11 |
major source | 11 |
food products | 11 |
selective binding | 11 |
phosphorylation sites | 11 |
will show | 11 |
peptides showed | 11 |
spent grain | 11 |
cantly increased | 11 |
potential use | 11 |
gastric emptying | 11 |
terminal end | 11 |
gnrh analogues | 11 |
structural elements | 11 |
sphingolipid metabolism | 11 |
animal feed | 11 |
weakly basic | 11 |
peptides isolated | 11 |
glycosylated peptides | 11 |
also involved | 11 |
embryonic stem | 11 |
newly developed | 11 |
significant reduction | 11 |
fl exibility | 11 |
heterologous expression | 11 |
achieved using | 11 |
family members | 11 |
different classes | 11 |
independent phospholipase | 11 |
membrane domains | 11 |
stem ethanol | 11 |
human influenza | 11 |
puerto rico | 11 |
peptide docking | 11 |
spatial resolution | 11 |
blood serum | 11 |
well characterized | 11 |
endophytic fungus | 11 |
induce apoptosis | 11 |
mouse peritoneal | 11 |
antibiotic activity | 11 |
specific protein | 11 |
tyrosine kinases | 11 |
transmission electron | 11 |
virulence factor | 11 |
protein domains | 11 |
primary cultures | 11 |
methanolic extract | 11 |
primrose oil | 11 |
conventional antibiotics | 11 |
case study | 11 |
expressing cells | 11 |
alkaline conditions | 11 |
dna synthesis | 11 |
inner membrane | 11 |
functional characterization | 11 |
also performed | 11 |
ionic strength | 11 |
cell debris | 11 |
cell lysates | 11 |
increased levels | 11 |
several types | 11 |
detection limit | 11 |
cantly decreased | 11 |
binding affinities | 11 |
biofi lm | 11 |
different chemical | 11 |
surgical patients | 11 |
peptide hybrids | 11 |
antibody binding | 11 |
fruit juice | 11 |
metabolic network | 11 |
platelet activation | 11 |
new peptides | 11 |
acid nanoparticles | 11 |
tetrafl uoroborates | 11 |
clinical evidence | 11 |
skeletal muscles | 11 |
atpase activity | 11 |
induced oxidative | 11 |
poor solubility | 11 |
significantly different | 11 |
triglyceride lipase | 11 |
differentially expressed | 11 |
anammox bacteria | 11 |
data bank | 11 |
membrane rafts | 11 |
growth regulators | 11 |
sar studies | 11 |
mannose glycans | 11 |
lactobacillus plantarum | 11 |
linked glycopeptides | 11 |
protein purification | 11 |
provide new | 11 |
specific antigen | 11 |
ed peptides | 11 |
surface proteins | 11 |
binding pocket | 11 |
inhibitory concentrations | 11 |
main chain | 11 |
highly variable | 11 |
plant polysaccharides | 11 |
higher levels | 11 |
expanded bed | 11 |
acid moiety | 11 |
induced diabetic | 11 |
drosophila melanogaster | 11 |
peptide complexes | 11 |
peptide chains | 11 |
consensus sequence | 11 |
mobile phase | 11 |
different proteins | 11 |
tissue culture | 11 |
klebsiella pneumoniae | 11 |
exclusion chromatography | 11 |
bovine coronavirus | 11 |
extract exhibited | 11 |
acid also | 11 |
several diseases | 11 |
healthy human | 11 |
covalently attached | 11 |
therapeutic strategies | 11 |
lipid membrane | 11 |
critical illness | 11 |
significant changes | 11 |
enzyme preparation | 11 |
force field | 11 |
peptide ligation | 11 |
novel method | 11 |
carboxyl groups | 11 |
virucidal activity | 11 |
fluorescent protein | 11 |
chemoenzymatic synthesis | 11 |
glucose homeostasis | 11 |
ph conditions | 11 |
kinase activity | 11 |
novel antimicrobial | 11 |
machine learning | 11 |
xylitol production | 11 |
keto acids | 11 |
chronic obstructive | 11 |
reperfusion injury | 11 |
small proteins | 11 |
dry matter | 11 |
membrane potential | 11 |
long time | 11 |
mouse liver | 11 |
methylene group | 11 |
cantly reduced | 11 |
whole blood | 11 |
useful tool | 11 |
atomic force | 11 |
carbon nanotubes | 11 |
specific antibodies | 11 |
fluorescence intensity | 11 |
false positives | 11 |
expression systems | 11 |
stearic acid | 11 |
polysia chains | 11 |
gm ganglioside | 11 |
rich proteins | 11 |
clinical nutrition | 11 |
peptide fragment | 11 |
play important | 11 |
succinic acid | 11 |
quite different | 11 |
less potent | 11 |
fl exible | 11 |
moderate wine | 11 |
clostridium perfringens | 11 |
oxidative damage | 11 |
universal exchange | 11 |
vibrio cholerae | 11 |
sars coronavirus | 11 |
kidney cells | 11 |
biological significance | 11 |
system using | 11 |
disease progression | 11 |
protein glycosylation | 11 |
acid delivery | 11 |
low level | 11 |
low mw | 11 |
amyloid fi | 11 |
cytotoxic effect | 11 |
allow us | 11 |
high school | 11 |
functional roles | 11 |
active center | 11 |
human embryonic | 11 |
genetically engineered | 11 |
synthetic methods | 11 |
phosphate dehydrogenase | 11 |
acetyl gd | 11 |
cell mass | 11 |
like growth | 11 |
membrane interactions | 11 |
see table | 11 |
care unit | 11 |
helical structures | 11 |
false positive | 11 |
common cold | 11 |
study showed | 11 |
base disturbances | 11 |
methanol extract | 11 |
molecular interactions | 11 |
canary islands | 11 |
proteome analysis | 11 |
genetically modified | 11 |
cellular delivery | 11 |
capsid protein | 11 |
affinity binding | 11 |
carboxylic group | 11 |
dna viruses | 11 |
arginine transport | 11 |
benefi cial | 11 |
controlled release | 11 |
milk oligosaccharides | 11 |
heavy metals | 11 |
intestinal secretion | 11 |
level digraph | 11 |
functional studies | 11 |
peptides corresponding | 11 |
specific sirna | 11 |
alkaline ph | 11 |
past years | 11 |
factor kappa | 11 |
also examined | 11 |
anthrax toxin | 11 |
coupling reagent | 11 |
milk fat | 11 |
beta cells | 11 |
biofilm formation | 11 |
increasing number | 11 |
modern humans | 11 |
dna repair | 11 |
obstructive pulmonary | 11 |
sequence alignment | 11 |
high concentration | 11 |
coupling reactions | 11 |
peptide concentration | 11 |
rat uterus | 11 |
momordica charantia | 11 |
data analysis | 11 |
terminal cysteine | 11 |
treated cells | 11 |
carcinoma cell | 11 |
plasma concentration | 11 |
leading cause | 11 |
transfer rate | 11 |
high amounts | 11 |
cell walls | 11 |
functional role | 11 |
significantly enhanced | 11 |
already known | 11 |
alkaline phosphatase | 11 |
nucleotide sequence | 11 |
novo design | 11 |
heavy chain | 11 |
fl uorinated | 11 |
metabolic activity | 10 |
lysosomal storage | 10 |
ml min | 10 |
stress conditions | 10 |
low mass | 10 |
mast cell | 10 |
molecular analysis | 10 |
intestinal epithelial | 10 |
type iii | 10 |
inhibitory action | 10 |
peptide molecules | 10 |
may serve | 10 |
site directed | 10 |
virus hemagglutinin | 10 |
overall yield | 10 |
inhibition activity | 10 |
activation energy | 10 |
glutamate receptor | 10 |
cyclic rgd | 10 |
group iii | 10 |
methods using | 10 |
chiral centers | 10 |
fermentation conditions | 10 |
food science | 10 |
time consuming | 10 |
rats treated | 10 |
ef fi | 10 |
bacterial cells | 10 |
phylogenetic tree | 10 |
mass spectrum | 10 |
one hand | 10 |
skin cancer | 10 |
protein family | 10 |
phase hplc | 10 |
regulatory peptides | 10 |
clinically relevant | 10 |
caffeoylquinic acids | 10 |
including cancer | 10 |
still unknown | 10 |
attractive target | 10 |
cas protein | 10 |
inflammatory effects | 10 |
cultures using | 10 |
pro residue | 10 |
regulatory mechanisms | 10 |
new technique | 10 |
protected peptide | 10 |
mediated via | 10 |
mouse mammary | 10 |
concentration range | 10 |
cells expressing | 10 |
antigenic determinants | 10 |
cellular processes | 10 |
mrna level | 10 |
phenolic content | 10 |
gynostemma pentaphyllum | 10 |
growth cones | 10 |
shock protein | 10 |
patients suffering | 10 |
stimulating hormone | 10 |
stimulatory effect | 10 |
preliminary data | 10 |
plant secondary | 10 |
enclosed within | 10 |
orthogonally protected | 10 |
basic protein | 10 |
geobacter sulfurreducens | 10 |
sulfate groups | 10 |
double bonds | 10 |
biological systems | 10 |
measured using | 10 |
viral envelope | 10 |
proinflammatory cytokines | 10 |
defined medium | 10 |
signalling pathways | 10 |
cleavage sites | 10 |
two enzymes | 10 |
phosphate pathway | 10 |
dpc micelles | 10 |
ray structure | 10 |
therapeutic targets | 10 |
bronchitis virus | 10 |
based therapies | 10 |
acidic amino | 10 |
total parenteral | 10 |
acid transporters | 10 |
pathogen interactions | 10 |
phagocytic activity | 10 |
acyl chains | 10 |
protein intake | 10 |
tissue regeneration | 10 |
acid moieties | 10 |
biochemical characterization | 10 |
peptide mass | 10 |
biotechnology institute | 10 |
also associated | 10 |
reverse transcription | 10 |
mg dl | 10 |
cytosolic phospholipase | 10 |
fluorescently labeled | 10 |
national research | 10 |
human ata | 10 |
orally active | 10 |
neonatal rat | 10 |
domain swapping | 10 |
trans isomerization | 10 |
histocompatibility complex | 10 |
dairy cows | 10 |
induced cell | 10 |
receptor determinant | 10 |
developmental stages | 10 |
small amount | 10 |
activity compared | 10 |
hydrolysis products | 10 |
scientific research | 10 |
many viruses | 10 |
acid esters | 10 |
aminopeptidase type | 10 |
pdb id | 10 |
antibody production | 10 |
based design | 10 |
animal species | 10 |
minimum inhibitory | 10 |
proteins may | 10 |
qc samples | 10 |
acids within | 10 |
may help | 10 |
salivary ph | 10 |
base pairs | 10 |
co incubator | 10 |
bacillus thuringiensis | 10 |
lund university | 10 |
antibiotic resistance | 10 |
food ingredients | 10 |
catalytic site | 10 |
east technical | 10 |
wang resin | 10 |
sulfate proteoglycans | 10 |
intestinal malabsorption | 10 |
bioactive peptide | 10 |
helix formation | 10 |
may affect | 10 |
epigallocatechin gallate | 10 |
ulcerative colitis | 10 |
cytometric analysis | 10 |
lipid membranes | 10 |
conformationally constrained | 10 |
individual proteins | 10 |
target gene | 10 |
consumption rate | 10 |
high efficiency | 10 |
several hundred | 10 |
various parts | 10 |
also called | 10 |
preclinical studies | 10 |
large variety | 10 |
human evolution | 10 |
bactericidal activity | 10 |
fi cation | 10 |
developmentally regulated | 10 |
cafeteria diet | 10 |
potential applications | 10 |
signalling pathway | 10 |
clinical application | 10 |
physiological state | 10 |
metabotropic glutamate | 10 |
storage diseases | 10 |
campylobacter jejuni | 10 |
coil structure | 10 |
corona virus | 10 |
peak areas | 10 |
proteins containing | 10 |
helix bundle | 10 |
culture media | 10 |
ion channel | 10 |
mg per | 10 |
analysis method | 10 |
selective enrichment | 10 |
parathyroid hormone | 10 |
comparative analysis | 10 |
neural cell | 10 |
dietary supplement | 10 |
new synthetic | 10 |
analyzed using | 10 |
potential role | 10 |
also contribute | 10 |
oxygen supply | 10 |
pressure test | 10 |
potentially useful | 10 |
vice versa | 10 |
neurological disorders | 10 |
stable isotope | 10 |
cellular functions | 10 |
specific inhibitors | 10 |
web servers | 10 |
optimal ph | 10 |
false negative | 10 |
dna sequencing | 10 |
natural peptide | 10 |
labeled proteins | 10 |
working volume | 10 |
placebo group | 10 |
released glycans | 10 |
high sensitivity | 10 |
atopic dermatitis | 10 |
body protein | 10 |
combinatorial chemistry | 10 |
heart failure | 10 |
coli strain | 10 |
rationally designed | 10 |
metabolic effects | 10 |
functional significance | 10 |
acetyl esterase | 10 |
serviceberry fruits | 10 |
analgesic activity | 10 |
alternative conceptions | 10 |
trichosanthes kirilowii | 10 |
general formula | 10 |
ceramide accumulation | 10 |
activated receptor | 10 |
novel class | 10 |
see also | 10 |
milk proteins | 10 |
increased resistance | 10 |
lymphocyte proliferation | 10 |
host sialic | 10 |
growth medium | 10 |
successfully used | 10 |
protein aggregation | 10 |
physical activity | 10 |
high doses | 10 |
white wine | 10 |
polysialic acids | 10 |
many studies | 10 |
metabolic energy | 10 |
cells involved | 10 |
induced dissociation | 10 |
novel human | 10 |
new family | 10 |
enzyme active | 10 |
peroxisome proliferator | 10 |
viral fusion | 10 |
general review | 10 |
sodium hydroxide | 10 |
cysteine proteases | 10 |
matrix metalloproteinase | 10 |
protein identification | 10 |
extract showed | 10 |
pore formation | 10 |
evaluated using | 10 |
potential drug | 10 |
lung carcinoma | 10 |
suffi cient | 10 |
leucine zipper | 10 |
present results | 10 |
cell response | 10 |
ace inhibitory | 10 |
three peptides | 10 |
connective tissue | 10 |
using synthetic | 10 |
sperm motility | 10 |
fragment condensation | 10 |
antifungal activities | 10 |
viral replication | 10 |
labeled peptides | 10 |
current evidence | 10 |
various concentrations | 10 |
transport systems | 10 |
intracellular ca | 10 |
optical density | 10 |
viral particles | 10 |
pipecolic acid | 10 |
nuclear extracts | 10 |
structurally characterized | 10 |
sambucus formosana | 10 |
within minutes | 10 |
cd cd | 10 |
traditionally used | 10 |
using solid | 10 |
anticancer agents | 10 |
medical applications | 10 |
chinese medicine | 10 |
cant decrease | 10 |